COVID-19 2022 update: transition of the pandemic to the endemic phase
M Biancolella, VL Colona, R Mehrian-Shai, JL Watt… - Human genomics, 2022 - Springer
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …
Here, we review the current state of research into the disease with focus on its history …
Favism and glucose-6-phosphate dehydrogenase deficiency
L Luzzatto, P Arese - New England Journal of Medicine, 2018 - Mass Medical Soc
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency When persons with G6PD
deficiency eat fava beans, acute hemolytic anemia may develop. It is caused by the …
deficiency eat fava beans, acute hemolytic anemia may develop. It is caused by the …
The economic and social burden of malaria
J Sachs, P Malaney - Nature, 2002 - nature.com
Where malaria prospers most, human societies have prospered least. The global distribution
of per-capita gross domestic product shows a striking correlation between malaria and …
of per-capita gross domestic product shows a striking correlation between malaria and …
Glucose-6-phosphate dehydrogenase deficiency
MD Cappellini, G Fiorelli - The lancet, 2008 - thelancet.com
Summary Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common
human enzyme defect, being present in more than 400 million people worldwide. The global …
human enzyme defect, being present in more than 400 million people worldwide. The global …
Glucose-6-phosphate dehydrogenase deficiency
G6PD was discovered and biochemically characterized in 1932 by Otto Warburg and Walter
Christian 1 in yeast and in red cells as an enzyme with a redox function. It was one of the first …
Christian 1 in yeast and in red cells as an enzyme with a redox function. It was one of the first …
[HTML][HTML] Ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden
JG Breman - The Intolerable Burden of Malaria: A New Look at the …, 2001 - ncbi.nlm.nih.gov
Malarious patients experience asymptomatic parasitemia; acute febrile illness (with cerebral
damage, anemia, respiratory distress, hypoglycemia); chronic debilitation (anemia …
damage, anemia, respiratory distress, hypoglycemia); chronic debilitation (anemia …
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries
Primaquine is the only available antimalarial drug that kills dormant liver stages of
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …
[HTML][HTML] Sickle cell anaemia and malaria
L Luzzatto - Mediterranean journal of hematology and infectious …, 2012 - ncbi.nlm.nih.gov
Sickle cell anaemia is a major chapter within haemolytic anaemias; at the same time, its
epidemiology is a remarkable signature of the past and present world distribution of …
epidemiology is a remarkable signature of the past and present world distribution of …
[PDF][PDF] Glucose-6-phosphate dehydrogenase deficiency
L Luzzatto, A Mehta, T Vulliamy - The metabolic and molecular …, 2001 - thebloodproject.com
G6PD was discovered and biochemically characterized in 1932 by Otto Warburg and Walter
Christian 1 in yeast and in red cells as an enzyme with a redox function. It was one of the first …
Christian 1 in yeast and in red cells as an enzyme with a redox function. It was one of the first …
G6 PD deficiency: a classic example of pharmacogenetics with on‐going clinical implications
L Luzzatto, E Seneca - British journal of haematology, 2014 - Wiley Online Library
That primaquine and other drugs can trigger acute haemolytic anaemia in subjects who
have an inherited mutation of the glucose 6‐phosphate dehydrogenase (G6 PD) gene has …
have an inherited mutation of the glucose 6‐phosphate dehydrogenase (G6 PD) gene has …